4

OWNERSHIP DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: August 14, 2020
Period of Report: August 12, 2020
Accession Number: 0001213900-20-022320

View Document ↗ View on SEC.gov ↗